Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Feb 2008

Zhang Yue, Li Lin, Nie Ling, Yu Yang, Yang Yi-Hong, Zhang Zhan-Qiang, Yang Lin, Xu Shi-Cai, Xiao Zhi-Jian

Abstract excerpt

OBJECTIVE: To investigate JAK2V617F mutation and its clinical significance in patients with chronic myeloproliferative disorders (cMPD). METHODS: A retrospective study was performed on 523 cMPD patients diagnosed according to the current World Health Organization (WHO) criteria. Allele-specific PCR (ASP) was used to identify JAK2V617F mutation, the mutation status was analyzed by PCR-RFLP, and the results were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles

Share to Chronic Disease

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Young Adult

Source

Identifiers

PMID: 18681311

Genes

JAK2
MPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].PMID 18681311Read ↗

[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].Semantic proximity Read ↗

[Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].Semantic proximity Read ↗

[JAK2 V617F mutation burden and its clinical implications in 415 patients with myeloproliferative neoplasm].Semantic proximity Read ↗

[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].Semantic proximity Read ↗

Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

[The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].Semantic proximity Read ↗

[The frequency of JAK2 V617F mutation, expression level of phosphorylated JAK/STATs proteins and their clinical significance in myeloproliferative disorders patients].Semantic proximity Read ↗

JAK2 V617F Mutational Burden and Clinical Findings Relationship in Myeloproliferative NeoplasmsSemantic proximity Read ↗

A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms].Semantic proximity Read ↗

[The clinical implication of JAK2 mutation expression in patients with myeloproliferative disorders].Semantic proximity Read ↗

Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.